| Literature DB >> 31852532 |
Angela Maria Moro1,2, Elisa Sauer1,3, Natália Brucker1,4, Mariele Feiffer Charão1,5, Bruna Gauer1,3, Sabrina Nunes do Nascimento1,3, Gabriela Goethel1,3, Marta Maria Medeiros Frescura Duarte6, Solange Cristina Garcia7,8.
Abstract
BACKGROUND: Gasoline is a complex mixture of saturated and unsaturated hydrocarbons, in which aromatic compounds, such as BTX (benzene, toluene, and xylene) feature as the main constituents. Simultaneous exposure to these aromatic hydrocarbons causes a significant impact on benzene toxicity. In order to detect early alterations caused in gasoline station attendants exposed to BTX compounds, immunological, inflammatory, and oxidative stress biomarkers were evaluated.Entities:
Keywords: Anti-inflammatory cytokines; Benzene; CD80; CD86; Glutathione S-transferase; Occupational toxicology; Pro-inflammatory cytokines; Protein carbonyl; Toluene; Xylene
Mesh:
Substances:
Year: 2019 PMID: 31852532 PMCID: PMC6921377 DOI: 10.1186/s40360-019-0355-1
Source DB: PubMed Journal: BMC Pharmacol Toxicol ISSN: 2050-6511 Impact factor: 2.483
Environmental and biological monitoring
| Non-exposed group ( | GSA group ( | ACGIH limits | |
|---|---|---|---|
| Benzene (μg m− 3) | 43.3 (35.3–63.3) | 105.9 (63.3–216.8)a | 1600.0 |
| Toluene (μg m− 3) | 107.4 (85.9–201.3) | 311.5 (207.7–578.2)a | 75,260.0 |
| 37.5 (23.0–224.4) | 59.4 (29.5–433.2)a | ||
| 20.1 (17.4–25.6) | 32.5 (27.8–37.4)a | 433,540.0* | |
| 21.2 (18.4–27.0) | 31.0 (22.2–34.6)a | ||
| 74.8 (47.6–121.5) | 421.9 (292.2–694.6)a | 500.0 | |
| HA (g g− 1 creatinine) | 0.3 (0.2–0.4) | 0.3 (0.2–0.6) | 1.6 |
| m-HA (g g− 1 creatinine) | n.d. | n.d. | 1.5 |
The values are expressed as median (interquartile range)
t,t-MA trans,trans-muconic acid, HA hippuric acid, mHA methylhippuric acid, n.d. not detectable
*total value to the sum of xylene isomers
ap < 0.001
Fig. 1Immunological biomarkers in GSA group (n = 38) and non-exposed group (n = 28). a CD80 expression in monocytes. b CD86 expression in monocytes. Data are expressed as mean ± SEM. *p < 0.001
Fig. 2Inflammatory biomarkers in GSA group (n = 38) and non-exposed group (n = 28). Data are expressed as mean ± SEM. *p < 0.001
Fig. 3Oxidative stress biomarkers in GSA group (n = 38) and non-exposed group (n = 28). a Protein carbonyl (PCO) levels. b Glutathione S-transferase (GST) activity. Data are expressed as mean ± SEM. *p < 0.001. **p < 0.05
Spearman’s correlations among personal BTX exposure, trans,trans-muconic acid, immunological, inflammatory, and oxidative stress biomarkers (n = 66)
| Benzene (μg m− 3) | Toluene (μg m− 3) | |||||
|---|---|---|---|---|---|---|
| CD80 monocyte expression (%) | ||||||
| CD86 monocyte expression (%) | ||||||
| IL-1β (pg mL− 1) | ||||||
| IL-6 (pg mL− 1) | ||||||
| IL-10 (pg mL− 1) | ||||||
| TNF-α (pg mL− 1) | ||||||
| INF-γ (pg mL− 1) | ||||||
| PCO (nmol mg− 1 protein) | ||||||
| GST (U GST mg− 1 protein) |
t,t-MA trans,trans-muconic acid, IL-1β interleukin-1β, IL-6 interleukin-6, IL-10 interleukin-10, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, PCO protein carbonyl, GST glutathione S-transferase
Correlations among biomarkers of effect (n = 66)
| Immunological biomarkers vs. Inflammatory biomarkers | |||||
| IL-1β (pg mL− 1) | IL-6 (pg mL− 1) | IL-10 (pg mL− 1) | TNF-α (pg mL− 1) | INF-γ (μg mL− 1) | |
| CD80 monocyte expression (%) | |||||
| CD86 monocyte expression (%) | |||||
| Immunological biomarkers vs. Oxidative Stress biomarkers | |||||
| PCO (nmol mg− 1 protein) | GST (U GST mg− 1 protein) | ||||
| CD80 monocyte expression (%) | |||||
| CD86 monocyte expression (%) | |||||
| Oxidative Stress biomarkers vs. Inflammatory biomarkers | |||||
| IL-1β (pg mL− 1) | IL-6 (pg mL− 1) | IL-10 (pg mL− 1) | TNF-α (pg mL− 1) | INF-γ (pg mL− 1) | |
| PCO (nmol mg− 1 protein) | |||||
| GST (U GST mg− 1 protein) | |||||
IL-1β interleukin-1β, IL-6 interleukin-6, IL-10 interleukin-10, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, PCO protein carbonyl, GST glutathione S-transferase
Correlations among exposure time and immunological, inflammatory, and oxidative stress biomarkers (n = 66)
| Exposure time (years) | |
|---|---|
| CD80 monocyte expression (%) | |
| CD86 monocyte expression (%) | |
| IL-1β (pg mL− 1) | |
| IL-6 (pg mL− 1) | |
| IL-10 (pg mL− 1) | |
| TNF-α (pg mL− 1) | |
| INF-γ (pg mL− 1) | |
| PCO (nmol mg− 1 protein) | |
| GST (U GST mg− 1 protein) |
IL-1β interleukin-1β, IL-6 interleukin-6, IL-10 interleukin-10, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, PCO protein carbonyl, GST glutathione S-transferase
Multiple linear regression models
| IL-1β (pg mL− 1) | IL-6 (pg mL− 1) | TNF-α (pg mL− 1) | INF-γ (pg mL− 1) | |||||
|---|---|---|---|---|---|---|---|---|
| Benzene (μg m−3)a | 0.437 | 0.519 | 0.496 | 0.388 | ||||
| Toluene (μg m−3)a | 0.213 | 0.270 | 0.221 | 0.268 | ||||
| − 0.250 | − 0.182 | − 0.333 | − 0.080 | |||||
| − 0.259 | − 0.285 | − 0.349 | − 0.177 | |||||
| − 0.319 | − 0.212 | −0.300 | −0.058 | |||||
| CD86 monocyte expression (%)a | −0.404 | −0.381 | −0.428 | −0.374 | ||||
| PCO (nmol mg−1 protein)a | 0.140 | 0.017 | 0.051 | 0.053 | ||||
| GST (U GST mg−1 protein)a | −0.165 | −0.071 | −0.196 | −0.155 | ||||
| Exposure time (years)a | −0.463 | −0.481 | −0.461 | −0.387 | ||||
| Age (years)a | 0.277 | 0.229 | 0.148 | 0.161 | ||||
| Smokingb | −0.129 | −0.087 | −0.085 | −0.123 | ||||
t,t-MA trans,trans-muconic acid, IL-1β interleukin-1β, IL-6 interleukin-6, TNF-α tumor necrosis factor-α, IFN-γ interferon-γ, PCO protein carbonyl, GST glutathione S-transferase
aCategorical variable
bContinuous variable